Abstract:Liucan Wang, &ast Guoqing Chen, &ast Yang Yang, Chao Xu, Li Zhu, Hua Yang, Min Yu Department of General Surgery, Chongqing General Hospital, Chongqing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Hua Yang; Min Yu, Email ; Oxidative stress, characterized by excessive production of reactive oxygen species (ROS), is a critical factor in the progression of inflammatory bowel disease (IBD) and presents a potential therapeutic target. Anti-oxidant therapy, aimed at mitigating excessive ROS, is emerging as a cornerstone in IBD treatment. Nanomaterials with robust anti-oxidant properties offer promise by inhibiting inflammation through ROS scavenging, enhancing IBD therapeutic efficacy. Recent focus in ROS scavenging has centered on metal oxide nanoenzymes and polyphenol-based nanomaterials. The primary challenges are the catalytic efficiency of nanoenzymes and the functional integration of these nanomaterials with therapeutic agents. Polyphenols, natural plant extracts, have garnered significant interest due to their potent anti-oxidant properties and unique catechol groups that interact with biomolecules such as proteins and nucleic acids. The strong metal ion chelating ability of catechols enriches the structure and functionality of nanomaterials, improving the physicochemical properties of nanocarriers and enabling innovative designs of multifunctional drug delivery systems (DDSs). Research on polyphenol-based DDSs has expanded to include agents like epigallocatechin gallate, curcumin, resveratrol, tannic acid, and polydopamine. These nanocarriers and anti-oxidants, which incorporate polyphenols, have demonstrated potential anti-oxidant properties in novel DDSs as therapeutic agents to reduce inflammation and as essential components of drug carriers. This review focuses on the design and application of natural polyphenol-based anti-oxidant nanomaterials for IBD treatment, offering a comprehensive discussion on the use of polyphenols in DDSs and the potential challenges posed by their diverse roles in innovative drug delivery strategies, including their impact on the physical and chemical properties of DDSs. Keywords: anti-oxidant therapy, polyphenols nanomaterial, ROS scavenging, inflammation inhibition Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), are chronic conditions that affect the gastrointestinal tract. These diseases are progressive and destructive, with an increasing incidence and prevalence. 1,2 Although the exact pathogenesis of IBD remains unclear, substantial evidence supports the dysregulation of inflammatory cytokines, such as IL-6, IL-10, TNF-α, and IL-1β, along with a significant increase in oxidative stress among patients. These factors are critical in triggering the development of IBD. 3–5 Current clinical therapies for IBD aim to induce remission using low molecular-weight pharmaceuticals, including amino-salicylates, corticosteroids, immunomodulators, and biologics. However, these treatments often have limited efficacy in clinical practice, facing challenges such as susceptibility to opportunistic infections, rapid clearance, limited functionality, and potential liver toxicity. 6–8 Notably, oxidative stress is known to drive the infiltration of neutrophils and macrophages into the intestinal mucosa at the site of IBD, resulting in the release of large quantities of reactive oxygen species (ROS) and inflammatory cytokines. 9 There is increasing evidence that the overproduction of ROS plays a critical role in the pathogenesis and progression of IBD. 10 Strategies that reduce inflammatory cytokines and scavenge ROS could alleviate IBD symptoms. 11–13 In this context, there is substantial potential for developing innovative therapies that effectively mitigate ROS-induced oxidative stress while exhibiting anti-inflammatory properties. Recently, nanomaterial-based interventions have emerged as promising strategies for mitigating inflammatory and oxidative damage in IBD. Among these, polyphenol-containing nanomaterials have gained extensive attention from researchers. Natural polyphenols are secondary metabolites with a polyphenolic structure, representing the predominant bioactive constituents derived from commonly consumed plants. The therapeutic potential of polyphenols in preventing or alleviating various metabolic disorders in humans has been convincingly demonstrated. 14 This naturally occurring group of substances includes a variety of compounds such as epigallocatechin gallate (EGCG), epigallocatechin (EGC), epicatechin gallate (ECG), catechin, tannic acid (TA), quercetin, gallic acid, gossypol, ellagic acid, resveratrol, caffeic acid, curcumin (CUR), rosmarinic acid (RA), a -Abstract Truncated-

Advancing Polyphenol-Based Nanomedicine for Inflammatory Bowel Disease: Challenges and Opportunities

Oxidative Stress, Inflammation, Gut Dysbiosis: What Can Polyphenols Do in Inflammatory Bowel Disease?

Oxidative Stress and Antioxidant Nanotherapeutic Approaches for Inflammatory Bowel Disease

Oxidative stress, hormones, and effects of natural antioxidants on intestinal inflammation in inflammatory bowel disease

Broad-Spectrum Reactive Oxygen Species Scavenging And Activated Macrophage-Targeting Microparticles Ameliorate Inflammatory Bowel Disease

Antioxidant Nanotherapies for the Treatment of Inflammatory Diseases

Orally Administrated Inflamed Colon-Targeted Nanotherapeutics for Inflammatory Bowel Disease Treatment by Oxidative Stress Level Modulation in Colitis

The progression of inorganic nanoparticles and natural products for inflammatory bowel disease

Oral Administration of Bioactive Nanoparticulates for Inflammatory Bowel Disease Therapy by Mitigating Oxidative Stress and Restoring Intestinal Microbiota Homeostasis

Foodomics-Based Approaches Shed Light on the Potential Protective Effects of Polyphenols in Inflammatory Bowel Disease

A drug-free nanozyme for mitigating oxidative stress and inflammatory bowel disease

Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel Disease

Reactive Oxygen Species-Responsive Polyether Micelle Nanomaterials for Targeted Treatment of Ulcerative Colitis

Wielding the double-edged sword: Redox drug delivery systems for inflammatory bowel disease

Polyoxometalate Nanoclusters: A Potential Preventative and Therapeutic Drug for Inflammatory Bowel Disease

Dietary polyphenols ameliorate inflammatory bowel diseases: advances and future perspectives to maximize their nutraceutical applications

An Oral Nano-Antioxidant for Targeted Treatment of Inflammatory Bowel Disease by Regulating Macrophage Polarization and Inhibiting Ferroptosis of Intestinal Cells

A Mesoporous Polydopamine-Derived Nanomedicine for Targeted and Synergistic Treatment of Inflammatory Bowel Disease by Ph-Responsive Drug Release and ROS Scavenging

Reactive oxygen species-responsive nanocarrier ameliorates murine colitis by intervening colonic innate and adaptive immune responses

Biocompatible Carbon Dots Nanozymes As ROS/RNS Modulators for Ulcerative Colitis Alleviation by Comprehensively Orchestrating Intestinal Homeostasis

ROS-responsive Nanoparticles Targeting Inflamed Colon for Synergistic Therapy of Inflammatory Bowel Disease Via Barrier Repair and Anti-Inflammation